The Spatial-Temporal Dimension of Oncological Prevalence and Mortality in Romania.
continuity of persistence
oncological mortality
oncological prevalence
persistence
Journal
GeoHealth
ISSN: 2471-1403
Titre abrégé: Geohealth
Pays: United States
ID NLM: 101706476
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
10
07
2023
revised:
18
08
2023
accepted:
27
08
2023
medline:
6
10
2023
pubmed:
6
10
2023
entrez:
6
10
2023
Statut:
epublish
Résumé
The objective of this study was to identify spatial disparities in the distribution of cancer hotspots within Romania. Additionally, the research aimed to track prevailing trends in cancer prevalence and mortality according to a cancer type. The study covered the timeframe between 2008 and 2017, examining all 3,181 territorial administrative units. The analysis of spatial distribution relied on two key parameters. The first parameter, persistence, measured the duration for which cancer prevalence exceeded the 75th percentile threshold. Cancer prevalence refers to the total number of individuals in a population who have been diagnosed with cancer at a specific time point, including both newly diagnosed cases (occurrence) and existing cases. The second parameter, the time continuity of persistence, calculated the consecutive months during which cancer prevalence consistently surpassed the 75th percentile threshold. Notably, persistence of elevated values was also evident in lowland regions, devoid of any discernible direct connection to environmental conditions. In conclusion, this work bears substantial relevance to regional health policies, by aiding in the formulation of prevention strategies, while also fostering a deeper comprehension of the socioeconomic and environmental factors contributing to cancer.
Identifiants
pubmed: 37799773
doi: 10.1029/2023GH000901
pii: GH2471
pmc: PMC10549965
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e2023GH000901Informations de copyright
© 2023 The Authors. GeoHealth published by Wiley Periodicals LLC on behalf of American Geophysical Union.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest relevant to this study.
Références
BMC Cancer. 2019 Jun 7;19(1):545
pubmed: 31174492
Int J Health Geogr. 2009 Sep 29;8:53
pubmed: 19785775
Health Policy. 2008 Aug;87(2):185-93
pubmed: 18243396
J Appl Stat. 2011 Mar;38(2):591-603
pubmed: 21475617
Ann Bot. 2017 Jan;119(2):215-228
pubmed: 28069633
BMC Public Health. 2013 Apr 26;13:395
pubmed: 23622426
Int J Environ Res Public Health. 2009 Dec;6(12):3190-204
pubmed: 20049256
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Semin Oncol. 1985 Mar;12(1):2-10
pubmed: 3975643
Cancers (Basel). 2023 May 19;15(10):
pubmed: 37345174
Int J Hyg Environ Health. 2007 Mar;210(2):113-9
pubmed: 17008129
Epidemiol Infect. 2016 Apr;144(5):940-51
pubmed: 26464184
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Int J Environ Res Public Health. 2023 May 04;20(9):
pubmed: 37174236
Strahlenther Onkol. 1990 Jun;166(6):377-86
pubmed: 2194302
MMWR Surveill Summ. 2010 Nov 26;59(9):1-25
pubmed: 21102407
Microcirculation. 1997 Dec;4(4):395-402
pubmed: 9431507
J Clin Oncol. 2006 May 10;24(14):2204-8
pubmed: 16682740
Int J Cancer. 2002 Feb 10;97(5):695-9
pubmed: 11807800
Am J Epidemiol. 1997 Mar 15;145(6):558-66
pubmed: 9063347
Exp Ther Med. 2022 Apr;23(4):259
pubmed: 35251325
Int J Cancer. 2007 Jan 1;120(1):121-7
pubmed: 17019706
Sci Rep. 2019 Aug 22;9(1):12228
pubmed: 31439903
Cancer Causes Control. 2020 Jul;31(7):609-615
pubmed: 32323050
Int J Environ Res Public Health. 2013 Dec 16;10(12):7207-28
pubmed: 24351742
Crit Rev Toxicol. 2006 Oct;36(9):727-76
pubmed: 17050083
Lancet Oncol. 2008 Feb;9(2):159-67
pubmed: 18237850
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Pharmaceutics. 2021 Dec 22;14(1):
pubmed: 35056915
BMC Public Health. 2022 Jan 13;22(1):90
pubmed: 35027042
Scand J Surg. 2006;95(4):218-24
pubmed: 17249268
Int J Biometeorol. 2017 Jan;61(1):137-147
pubmed: 27329324
Med Phys. 1995 Apr;22(4):381-90
pubmed: 7609718
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):485-95
pubmed: 23462925
Eur J Cancer Prev. 1996 Oct;5(5):319-27
pubmed: 8972250
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Genet Epidemiol. 2013 Nov;37(7):643-57
pubmed: 24123198
MMWR Surveill Summ. 2017 Jul 07;66(14):1-13
pubmed: 28683054
BMC Infect Dis. 2016 May 26;16:233
pubmed: 27230283
J Int AIDS Soc. 2010 Oct 27;13:41
pubmed: 20979651
Eur J Epidemiol. 1999 Jan;15(1):15-22
pubmed: 10098991
Int J Environ Res Public Health. 2020 Nov 03;17(21):
pubmed: 33153024
Int J Environ Res Public Health. 2014 Jan 28;11(2):1479-99
pubmed: 24477211
Gastroenterology. 2020 Jan;158(2):354-367
pubmed: 31682851
Gut. 2013 Apr;62(4):630-49
pubmed: 23335431
J Clin Med. 2022 Apr 18;11(8):
pubmed: 35456357
Lancet. 2013 Oct 19;382(9901):1329-40
pubmed: 23915883
Nat Rev Cancer. 2004 Nov;4(11):909-17
pubmed: 15516963
N Engl J Med. 1997 May 15;336(20):1401-8
pubmed: 9145676
Lancet. 2015 Mar 14;385(9972):977-1010
pubmed: 25467588
Int J Radiat Oncol Biol Phys. 1993 Feb 15;25(3):481-9
pubmed: 8436527
BMC Cancer. 2006 Nov 10;6:264
pubmed: 17096841
J Gen Intern Med. 2019 Mar;34(3):412-419
pubmed: 30652275
Soc Sci Med Med Geogr. 1979 Jun;13 D(2):123-30
pubmed: 494010
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Diagnostics (Basel). 2022 Mar 18;12(3):
pubmed: 35328289
Am J Public Health. 1995 Jul;85(7):944-8
pubmed: 7604918
Med Phys. 1996 Aug;23(8):1337-45
pubmed: 8873030
Health Commun. 2012;27(8):806-17
pubmed: 22356137
PLoS One. 2018 Oct 2;13(10):e0205005
pubmed: 30278073
Acta Oncol. 2016 Sep - Oct;55(9-10):1158-1160
pubmed: 27551890
Anal Quant Cytol Histol. 1993 Apr;15(2):144-9
pubmed: 8318129
Cancer. 2019 Aug 1;125(15):2544-2560
pubmed: 31145834
Iran J Public Health. 2012;41(11):1-9
pubmed: 23304670
Int J Environ Res Public Health. 2015 Dec 17;12(12):16005-18
pubmed: 26694437
J Air Waste Manag Assoc. 2002 Sep;52(9):1032-42
pubmed: 12269664
World J Gastroenterol. 2006 Jan 21;12(3):354-62
pubmed: 16489633
Stat Methods Med Res. 2017 Oct;26(5):2244-2256
pubmed: 26220537
Genes Immun. 2023 Feb;24(1):1-11
pubmed: 36585519
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Am J Prev Med. 2006 Feb;30(2 Suppl):S25-36
pubmed: 16458787
Cancers (Basel). 2022 Jan 13;14(2):
pubmed: 35053559
J Pathol. 1997 May;182(1):1-8
pubmed: 9227334
J Biomech Eng. 1999 Oct;121(5):480-6
pubmed: 10529914
PLoS Med. 2013;10(4):e1001413
pubmed: 23565065
Comput Biol Med. 2020 Oct;125:103971
pubmed: 32861050
Eye (Lond). 1990;4 ( Pt 1):235-41
pubmed: 2323476